Omaxe sees a credit rating action

OMAXE’s current public shareholding is 25.86% in the latest validated Q4 FY26 shareholding pattern.

• MPS requirement: 25.00%
• Public-shareholding surplus: 0.86 percentage points
• Promoter holding: 74.14%, below the 75.00% maximum permitted under the 25% MPS rule
• Promoter divestment required: 0 shares; 0.00 percentage points

Therefore, the company already satisfies the MPS requirement. The 0.86 percentage-point excess is a compliance buffer, not a mandatory divestment quantum.

The order does not name NCDs, rights issues, or any other specific financing instrument. Its operative restriction is broad: Omaxe is barred for three months from accessing the securities market and from directly or indirectly dealing in securities; the named promoters and related entities face a one-year restriction. ^[1] Separate coverage reproduces the wider wording as prohibiting buying, selling or otherwise dealing in securities, including mutual-fund units, or being associated with the securities market. ^[2]

What appears to be restricted

• NCDs: Not separately named in the disclosed order language. A fresh NCD issue would nevertheless require careful legal review because it involves issuance/dealing in securities and may fall within the broad market-access restriction.
• Rights issue or other equity issue: Not separately named. A rights issue would also potentially involve access to the securities market and dealing in securities, so it should not be treated as permissible merely because the order does not use the term “rights issue.”
• Private placements, listed debt, warrants, or other securities transactions: No instrument-specific carve-out is reported in the cited directions. The order instead uses a broad securities-market prohibition. ^[1]
• Ordinary bank borrowing: The reproduced directions do not specifically mention bank loans or bilateral borrowing. Whether a particular refinancing is outside the order would depend on the structure and legal interpretation; the disclosure does not provide a blanket exemption.

Existing debt maturity bucket

The latest classified consolidated balance-sheet figures are for FY26. They show the following broad contractual maturity buckets:

On a derived basis, current borrowings represented approximately 11.09% of consolidated debt, while non-current borrowings represented approximately 88.91%. This is derived from the reported current borrowings of Rs 158.10 Crores and non-current borrowings of Rs 1,267.10 Crores against total debt of Rs 1,425.20 Crores. ^{[3] [4] [5]}

Refinancing implication: the immediately relevant refinancing pool is the Rs 158.10 Crores classified as current debt, but the available balance-sheet data does not split it into monthly or quarterly maturities. Therefore, it cannot establish how much falls due during Omaxe’s three-month restriction. The Rs 1,267.10 Crores non-current balance is not an immediate three-month maturity bucket, although individual facilities within it could contain scheduled amortisation or earlier refinancing requirements that are not visible from the reported classification.

No specific compliance timeline or disposal method has been submitted in the cited exchange disclosure. Omaxe’s intimation only states that it received SEBI’s order dated September 24, 2026 on September 25, 2026, and that it is examining the order and evaluating available legal remedies. It does not commit to an Offer for Sale, institutional placement, QIP, or any other method of restoring MPS compliance. ^[6]

The SEBI order itself imposes a three-month restriction on Omaxe’s access to the securities market, effective from the order date, but the exchange intimation does not translate this into a separate MPS-compliance deadline or execution timetable. ^[1]

Prior correspondence or extension requests: The disclosure does not mention any earlier correspondence with SEBI or the stock exchanges, nor any request for additional time or extension concerning the MPS non-compliance. This means no such correspondence or request was disclosed in the cited filing—not necessarily that none occurred.